Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.01
Price to sales ratio
0.21

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4424
RMTI
Rockwell Medical, Inc. - Common Stock
8.17 USD+5.42%+2.77%+17.39%+327.75%32.93 M USD
4492
TXMD
TherapeuticsMD, Inc. - Common Stock
2.22 USD0.00%+7.77%+9.36%+111.43%25.70 M USD
4520
BFRI
Biofrontera Inc. - Common Stock
1.59 USD+6.71%+7.43%+34.75%+84.88%23.62 M USD
4831
AKAN
Akanda Corp. - Common Shares
3.89 USD-8.04%0.00%-39.78%+4.85%7.72 M USD

Frequently asked questions about AYTU BioPharma, Inc. Common Stock

What is the AYTU BioPharma, Inc. Common Stock stock price today?

The current price of AYTU BioPharma, Inc. Common Stock (AYTU) is 2.25. Over the past 24 hours, the stock has changed by +0.45%. Follow the AYTU chart for real-time price dynamics.

What is the stock ticker of AYTU BioPharma, Inc. Common Stock?

AYTU BioPharma, Inc. Common Stock trades under the ticker AYTU. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is AYTU BioPharma, Inc. Common Stock stock going up?

AYTU has changed by -4.26% over the last week, +4.17% over the last month, and -4.66% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of AYTU BioPharma, Inc. Common Stock?

AYTU BioPharma, Inc. Common Stock currently has a market capitalization of 24.15 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were AYTU BioPharma, Inc. Common Stock earnings last quarter?

Last quarter, AYTU BioPharma, Inc. Common Stock reported earnings of -0.53 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was AYTU BioPharma, Inc. Common Stock revenue for the last quarter?

AYTU BioPharma, Inc. Common Stock reported quarterly revenue of 12.41 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was AYTU BioPharma, Inc. Common Stock net income for the last quarter?

AYTU BioPharma, Inc. Common Stock reported net income of -5.62 M for the last quarter. The previous quarter showed -10.58 M, which means net income changed by +46.92%.

How many employees does AYTU BioPharma, Inc. Common Stock have?

As of the latest available data, AYTU BioPharma, Inc. Common Stock has 83 employees. Workforce size can provide additional context about the company's scale and operations.

What is AYTU BioPharma, Inc. Common Stock EBITDA?

AYTU BioPharma, Inc. Common Stock EBITDA is -2.85 M, and its EBITDA margin is -22.96%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy AYTU BioPharma, Inc. Common Stock stock?

You can buy AYTU BioPharma, Inc. Common Stock (AYTU) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in AYTU BioPharma, Inc. Common Stock stock?

Investing in AYTU BioPharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AYTU chart and related analysis on metatrader.com as part of your research.

News